ABSTRACT
BACKGROUND: Women in poor urban neighborhoods have high rates of stress and allergic diseases, but whether stress or stress correlates such as depression promote inflammatory and type 2 cytokine responses is unknown. OBJECTIVE: To examine associations among external stressors, perceived stress, depression, and peripheral blood mononuclear cell cytokine responses of mothers enrolled in the Urban Environment and Childhood Asthma Study and test the hypothesis that stress would be positively associated with type 2 and selected proinflammatory (tumor necrosis factor-α and interleukin-8) responses. METHODS: Questionnaire data from mothers living in 4 inner cities included information about external stress, stress perception, and depression. The external stress domains (interpersonal problems, housing, and neighborhood stress) were combined into a Composite Stressor score. Peripheral blood mononuclear cells were stimulated ex vivo and cytokine responses to innate, adaptive, and polyclonal immune stimuli were compared with stress and depression scores for 469 of the 606 study participants. RESULTS: There were no significant positive associations between Composite Stressor scores, perceived stress, or depression scores and proinflammatory or type 2 cytokine responses, and these findings were not modified by allergy or asthma status. There were some modest associations with individual stressors and cytokine responses, but no consistent relations were noted. Depression was associated with decreased responses to some stimuli, particularly dust mite. CONCLUSION: Composite measurements of stressors, perceived stress, or depression were not positively related to proinflammatory or type 2 cytokine responses in these young urban women. These data do not support the hypothesis that these factors promote cytokine responses associated with allergy. TRIAL REGISTRATION: ClinicalTrials.gov, identifier NCT00114881.
Subject(s)
Cytokines/immunology , Interleukin-8/immunology , Stress, Psychological/immunology , Tumor Necrosis Factor-alpha/immunology , Adolescent , Adult , Asthma/immunology , Depression/immunology , Female , Humans , Hypersensitivity/immunology , Leukocytes, Mononuclear/immunology , Mothers , Residence Characteristics , Urban Population , Young AdultABSTRACT
PURPOSE OF REVIEW: Allergic reactions to stinging insects may be unexpected, frightening, and severe. A clear understanding of recent advances in the field facilitates appropriate care of children who experience severe reactions to hymenoptera stings. RECENT FINDINGS: Recent investigations have underscored the importance of appropriate patient selection for potentially life-saving venom immunotherapy. Venom immunotherapy is effective in preventing future anaphylaxis from hymenoptera stings. Immunotherapy is indicated for patients with a history of anaphylaxis. Children who develop large local swelling or strictly cutaneous systemic reactions generally do not require immunotherapy. Component resolved diagnostic testing has been investigated to clarify the possibility of multiple venom allergies in patients with sensitization to multiple venoms. SUMMARY: Rapid recognition and treatment of anaphylaxis are critical. Subsequent education about avoiding future stings and attention to emergency preparedness with appropriate prescription of self-injectable epinephrine is important. Referral of patients who have experienced venom-associated anaphylaxis for possible venom immunotherapy can prevent future severe episodes of anaphylaxis resulting from stings.
Subject(s)
Anaphylaxis/therapy , Arthropod Venoms/immunology , Desensitization, Immunologic/methods , Insect Bites and Stings/immunology , Anaphylaxis/immunology , Animals , Arthropod Venoms/therapeutic use , Child , Child, Preschool , Humans , Hymenoptera , Insect Bites and Stings/complications , Patient Selection , Referral and ConsultationSubject(s)
Angioedema/diagnosis , Lymphoma, B-Cell, Marginal Zone/diagnosis , Abdominal Pain/etiology , Aged, 80 and over , Angioedema/etiology , Antibodies, Monoclonal, Murine-Derived/therapeutic use , Antineoplastic Agents/therapeutic use , Female , Humans , Lymphoma, B-Cell, Marginal Zone/drug therapy , Rituximab , Splenomegaly/diagnosisABSTRACT
PURPOSE OF REVIEW: Egg allergy is a common problem affecting young children especially. There has been much debate over the past several decades on how to approach the subject of influenza vaccination in children with egg allergy. RECENT FINDINGS: Because of concern regarding the egg protein content in the influenza virus vaccine, pediatricians have in the past typically taken a conservative approach of avoiding influenza vaccination in egg-allergic patients. Subsequently, it was shown that the influenza vaccine could be safely administered to patients who had negative skin testing to the vaccine. Most recently, studies have demonstrated a low risk of giving the vaccine either in divided doses or as a single dose in a controlled setting without the need for skin testing. SUMMARY: In considering vaccination in a patient with a history of egg allergy, several factors should be weighed, including the severity of the egg allergy, the egg content of vaccines, and the setting of vaccine administration. However, it appears that the risk of anaphylaxis to the influenza vaccine in patients with egg allergy may be much lower than previously thought, suggesting that in many cases skin testing may not be necessary.
Subject(s)
Egg Hypersensitivity , Egg Proteins/adverse effects , Influenza Vaccines/adverse effects , Humans , Influenza Vaccines/administration & dosage , Influenza Vaccines/chemistry , Influenza, Human/prevention & control , Practice Guidelines as Topic , RiskSubject(s)
Interleukin-12 Receptor beta 1 Subunit , Mycobacterium avium-intracellulare Infection , Pneumococcal Infections/microbiology , Sepsis , Codon, Nonsense , Consanguinity , Female , Humans , Infant , Interleukin-12 Receptor beta 1 Subunit/deficiency , Interleukin-12 Receptor beta 1 Subunit/genetics , Mycobacterium avium Complex , Mycobacterium avium-intracellulare Infection/genetics , Mycobacterium avium-intracellulare Infection/immunology , Mycobacterium avium-intracellulare Infection/microbiology , Pneumococcal Infections/genetics , Pneumococcal Infections/immunology , Sepsis/genetics , Sepsis/immunology , Sepsis/microbiology , Streptococcus pneumoniae , United StatesABSTRACT
BACKGROUND: Long stays in the intensive care unit are associated with high costs and burdens on patients and patients' families and in turn affect society at large. Although factors that affect length of stay and outcomes of care in the intensive care unit have been studied extensively, the conclusions reached have not been reviewed to determine whether they reveal an organizational pattern that might be of practical use in reducing length of stay in the unit. OBJECTIVE: To identify and categorize the factors associated with prolonged stays in the intensive care unit and to describe briefly the nonmedical interventions to date designed to reduce length of stay. METHODS: Articles published between January 1990 and March 2005 in English-language journals indexed by MEDLINE were searched for studies on outcomes and costs of care in the intensive care unit and on care at the end of life. RESULTS: The emerging consensus is that length of stay in the intensive care unit is exacerbated by several increasingly discernible medical, social, psychological, and institutional factors. At the same time, several nonmedical, experimental interventions have been designed to reduce length of stay. CONCLUSIONS: Interventions involving palliative care, ethics consultations, and other methods to increase communication between healthcare personnel, patients, and patients' families may be helpful in decreasing length of stay in the intensive care unit. Further studies are needed to provide a strategy for targeting specific risk factors indicated by the literature review.